Besides the garbage on Sierra World Equity Review:
HEADLINE: In Full Swing_ Abbott Laboratories (ABT) To Announce Joint Venture With Cutting Edge 3-D Bioprinting Technology Pioneer Organovo Holdings (ONVO) Predicts Sierra World Equity Review. Abbott Laboratories (ABT) New Joint Venture This evening Sierra has issued a new buy rating for Organovo Holdings with a 10 day short term price target of $12.85. Sierra's leads indicate that Abbott Laboratories (ABT) is currently working to secure an agreement with Organovo Holdings as it hedges it's future bets on the exciting potential of 3-D bioprinting technology. Sierra and her team anticipate that an announcement could come prior to mid December, check back for instant updates as Sierra follows developments.